US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Bayer A.G.

13.41

-0.2400-1.76%

Post-market: 13.420.0100+0.07%16:00 EST

Volume:2.85M

Turnover:38.30M

Market Cap:52.70B

PE:-226.83

High:13.52

Open:13.38

Low:13.35

Close:13.65

52wk High:13.98

52wk Low:5.30

Shares:3.93B

Float Shares:3.93B

Volume Ratio:1.12

T/O Rate:0.07%

Dividend:0.03

Dividend Rate:0.23%

EPS(TTM):-0.0591

EPS(LYR):-0.6723

ROE:-0.57%

ROA:3.06%

PB:1.51

PE(LYR):-19.95

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

Bayer Cleared to Offer Stryax After EPA Registers Dicamba Herbicides

Bayer's Asundexian Data Are Better Than Hoped -- Market Talk

Bayer says Asundexian showed 26% reduction in stroke in Phase III study

European Pharmaceutical Stocks Follow U.S. Peers Down -- Market Talk

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/BAYRY"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BAYRY","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BAYRY\",,,,,undefined,":{"symbol":"BAYRY","market":"US","secType":"STK","nameCN":"Bayer A.G.","latestPrice":13.41,"timestamp":1770411600000,"preClose":13.65,"halted":0,"volume":2852873,"hourTrading":{"tag":"盘后","latestPrice":13.42,"preClose":13.41,"latestTime":"16:00 EST","volume":1272,"amount":17070.24,"timestamp":1770411620884,"change":0.01,"changeRate":0.000746,"amplitude":0},"delay":15,"changeRate":-0.017582417582417596,"floatShares":3929259738,"shares":3929696328,"eps":-0.059118,"marketStatus":"Closed","change":-0.24,"latestTime":"02-06 16:00:20 EST Delay","open":13.38,"high":13.52,"low":13.35,"amount":38298001.90940003,"amplitude":0.012454,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":-0.059118,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1770627600000},"marketStatusCode":5,"adr":0,"adrRate":0.25,"exchange":"OTCQX","adjPreClose":13.65,"volumeRatio":1.122924},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BAYRY\",,,,,undefined,":{"symbol":"BAYRY","floatShares":3929259738,"roa":"3.06%","roe":"-0.57%","lyrEps":-0.672343,"volumeRatio":1.122924,"shares":3929696328,"dividePrice":0.031,"high":13.52,"amplitude":0.012454,"preClose":13.65,"low":13.35,"week52Low":5.3,"pbRate":"1.51","psRate":"0.97","week52High":13.98,"institutionHeld":0.0018,"latestPrice":13.41,"eps":-0.059118,"divideRate":0.002312,"volume":2852873,"delay":15,"ttmEps":-0.059118,"open":13.38,"prevYearClose":10.82,"prevWeekClose":13.15,"prevMonthClose":13.15,"prevQuarterClose":10.82},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BAYRY\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-05-13","symbol":"BAYRY","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1747108800000,"reportTimeType":"","actualEps":null},{"date":"2025-04-29","symbol":"BAYRY","amount":0.030365,"announcedDate":"2025-04-04","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-04-29","defaultRemindTime":1745933400000,"name":"Bayer A.G.","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-05-12","payableDate":"2025-04-29","currency":"USD","dateTimestamp":1745899200000,"payDate":"2025-05-12"},{"market":"US","date":"2024-11-12","symbol":"BAYRY","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1731387600000,"reportTimeType":"","actualEps":null},{"date":"2024-08-06","symbol":"BAYRY","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1722974400000,"name":null,"time":"Post Market","dateTimestamp":1722916800000,"actualEps":null},{"date":"2024-05-14","symbol":"BAYRY","type":"earning","reportTimeType":"","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1715673600000,"name":null,"time":"","dateTimestamp":1715659200000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BAYRY\",market:\"US\",,,undefined,":[{"executeDate":"2016-04-27","recordDate":"2016-04-29","paymentDate":"2016-05-12","value":2.091196,"currency":"USD"},{"executeDate":"2019-04-29","recordDate":"2019-04-30","paymentDate":"2019-05-13","value":0.550569,"currency":"USD"},{"executeDate":"2020-04-29","recordDate":"2020-04-30","paymentDate":"2020-05-14","value":0.535933,"currency":"USD"},{"executeDate":"2021-04-28","recordDate":"2021-04-29","paymentDate":"2021-05-10","value":0.407111,"currency":"USD"},{"executeDate":"2022-05-02","recordDate":"2022-05-03","paymentDate":"2022-05-16","value":0.549114,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BAYRY\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3333,"buy":0.3333,"hold":0.3333,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.3333,"analysts":3,"updateTime":1763096400000},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BAYRY\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2609171045","title":"Bayer Cleared to Offer Stryax After EPA Registers Dicamba Herbicides","url":"https://stock-news.laohu8.com/highlight/detail?id=2609171045","media":"Dow Jones","labels":["productRelease"],"top":1,"itemType":null,"share":"https://ttm.financial/m/news/2609171045?lang=en_us&edition=fundamental","pubTime":"2026-02-07 07:44","pubTimestamp":1770421440,"startTime":"0","endTime":"0","summary":"Bayer can now offer its Stryax herbicide following government approval.The Environmental Protection Agency registered low-volatility dicamba herbicides in 34 states, which opens the door for Bayer to launch Stryax, a restricted use pesticide, the company said Friday.The German pharmaceuticals and agricultural products maker now plans to seek state approvals, said Ty Witten, head of Bayer's commercial stewardship in crop science.Stryax helps manage glyphosate-resistant broadleaf weeds and other tough to control weeds. It also offers up to 14 days of soil activity in certain weeds, helping farmers keep fields clean, Bayer said.The pesticide was designed as an additional herbicide option for in-crop use with XtendFlex soybeans, Roundup Ready 2 Xtend soybeans and cotton with XtendFlex technology.The registration allows for the use of approved low-volatility dicamba herbicides in-crop up to 7 days pre-harvest in XtendFlex cotton and up through R1 in XtendFlex soybeans.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Bayer Cleared to Offer Stryax After EPA Registers Dicamba Herbicides","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BAYRY"],"gpt_icon":0},{"id":"2609568197","title":"Bayer's Asundexian Data Are Better Than Hoped -- Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2609568197","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609568197?lang=en_us&edition=fundamental","pubTime":"2026-02-06 16:15","pubTimestamp":1770365700,"startTime":"0","endTime":"0","summary":"0815 GMT - Bayer released data for its asundexian drug candidate for stroke prevention that seem better than hoped and support an optimistic view on the medicine's potential, analysts at Morgan Stanley say. The German pharma-to-agriculture group said asundexian reduced by 26% the risk of recurrent stroke in patients who experienced an initial stroke compared to placebo. The efficacy results are very strong and came alongside a more favorable safety profile than expected, the analysts say in a research note. The data represent a bull-case outcome for asundexian, they add. Morgan Stanley estimates the drug could generate annual peak sales of 4 billion euros in secondary stroke prevention. Bayer shares rise 0.3%. ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Bayer's Asundexian Data Are Better Than Hoped -- Market Talk","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2347655156.SGD","LU1732800096.USD","LU1244550494.USD","LU0528227936.USD","LU0225283273.USD","LU1548497426.USD","LU0912757837.SGD","LU0267386448.USD","LU2023251221.USD","LU0158827781.USD","BK4581","IE00BKVL7J92.USD","LU0882574139.USD","BK4585","LU2357305700.SGD","BK4127","LU0098860793.USD","LU1732799900.SGD","LU1989772923.USD","BK4504","LU0795875169.SGD","LU1720051108.HKD","LU0106831901.USD","LU1162221912.USD","BK4534","LU0006306889.USD","LU0795875086.SGD","LU2111349929.HKD","LU0234570918.USD","LU0971096721.USD","BK4588","IE00BZ1G4Q59.USD","BK4007","BAYRY","LU2028103732.USD","LU2089284900.SGD","LU0557290698.USD","LU0158827948.USD","LU0320765646.SGD","LU1244550577.SGD","LU1363072403.SGD","LU2133065610.SGD","LU1791710400.SGD","LU2089283258.USD","LU1720051017.SGD","LU1244550221.USD","BK4516","LU1989772840.SGD","LU0106261372.USD","LU1074936037.SGD"],"gpt_icon":0},{"id":"2609588206","title":"Bayer says Asundexian showed 26% reduction in stroke in Phase III study","url":"https://stock-news.laohu8.com/highlight/detail?id=2609588206","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609588206?lang=en_us&edition=fundamental","pubTime":"2026-02-06 01:20","pubTimestamp":1770312017,"startTime":"0","endTime":"0","summary":"Bayer (BAYRY) presented the results from the global, pivotal Phase III OCEANIC-STROKE study evaluating the use of its investigational, once-daily, ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/bayer-says-asundexian-showed-26-reduction-in-stroke-in-phase-iii-study-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/bayer-says-asundexian-showed-26-reduction-in-stroke-in-phase-iii-study-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["III","BK4007","BK4134","BAYRY"],"gpt_icon":0},{"id":"2606910792","title":"European Pharmaceutical Stocks Follow U.S. Peers Down -- Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2606910792","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606910792?lang=en_us&edition=fundamental","pubTime":"2026-01-28 18:17","pubTimestamp":1769595420,"startTime":"0","endTime":"0","summary":"Copyright (c) 2026 Dow Jones & Company, Inc.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RHHBY","BK4532","BK4599","03165","GSK","LU1093756325.SGD","BAYRY","IE00BKVL7J92.USD","IE00BZ1G4Q59.USD","BK4585","IE00BFXG1179.USD","LU0154236417.USD","NVO","SDZNY","BK4007","LU1093756168.USD","BK4588"],"gpt_icon":1}],"pageSize":4,"totalPage":9,"pageCount":1,"totalSize":33,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/BAYRY\",params:#limit:6,delay:false,,,undefined,":[]}}